Redesign Health operates as a mission-driven healthcare firm focused on launching and supporting healthcare companies. Through its platform, it aids in developing technologies, tools, and information to reduce barriers to industry change. The company provides founders with access to funding and expert support, empowering the healthcare ecosystem to accelerate processes in areas such as cancer care, teleradiology, COVID-19 testing, and metabolic health.

Investors Include:

Eden Global Partners, CVS Health Ventures, Blisce, RiverPark Ventures, Greycroft, UPMC Enterprises, General Advance, Declaration Partners, Euclidean Capital, TriplePoint Capital, Samsung NEXT Ventures, Gaingels, Westway Capital, General Catalyst, Centre Street Partners, Reshape (Investor).

Collective explained in 2 minutes

Learn how Collective's solutions enable you to manage your risk and maximize your wealth

Learn more

Our available services for this company

Lifetime IncomeCharitable Remainder Trust

Tax SavingsDonor Advised Fund